COPD Research

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Martin R. Stämpfli, PhD, professor in the department of medicine at McMaster University, explains the development of COPD in his lecture at the seminar “COPD—Bridging the Gap between Science and Clinical Care.”

Related Articles
The flavorings used to improve the taste of electronic cigarettes may pose their own respiratory health hazards.
In a study of patients with comorbid COPD and metabolic syndrome, elevated triglyceride levels were associated with increased mortality rates.
The FDA is reviewing a regulatory application to add an asthma indication to Boehringer Ingelheim’s chronic obstructive pulmonary disease treatment, tiotropium bromide.
AstraZeneca today announced that it has completed the strategic transaction to transfer the rights to Almirall’s respiratory franchise to the company.
Latest Issues
$auto_registration$